Evidence map›Paper›PMID 36245792›Full record

ArticleFrontiers in toxicology2022

The alamar blue assay in the context of safety testing of nanomaterials.

Eleonora Marta Longhin, Naouale El Yamani, Elise Rundén-Pran, Maria Dusinska

Abstract read
In one paragraph

Article in Frontiers in toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Non-target influence of natural insecticide neem oil on bacterial growth and metabolism.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eleonora Marta LonghinHealth Effects Laboratory, Department for Environmental Chemistry, NILU-Norwegian Institute for Air Research, Kjeller, Norway.
Naouale El YamaniHealth Effects Laboratory, Department for Environmental Chemistry, NILU-Norwegian Institute for Air Research, Kjeller, Norway.
Elise Rundén-PranHealth Effects Laboratory, Department for Environmental Chemistry, NILU-Norwegian Institute for Air Research, Kjeller, Norway.
Maria DusinskaHealth Effects Laboratory, Department for Environmental Chemistry, NILU-Norwegian Institute for Air Research, Kjeller, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Alamar Blue (AB) assay is widely used to investigate cytotoxicity, cell proliferation and cellular metabolic activity within different fields of toxicology. The use of the assay with nanomaterials (NMs) entails specific aspects including the potential interference of NMs with the test. The procedure of the AB assay applied for testing NMs is described in detail and step-by-step, from NM preparation, cell exposure, inclusion of interference controls, to the analysis and interpretation of the results. Provided that the proper procedure is followed, and relevant controls are included, the AB assay is a reliable and high throughput test to evaluate the cytotoxicity/proliferation/metabolic response of cells exposed to NMs.

Indexed as

alamar bluecellular metabolic activitycytotoxicitynanomaterialsnanoparticlesviability

Identifiers

PMID36245792
PMCPMC9554156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.